ID: ALA5203362
Chembl Id: CHEMBL5203362
PubChem CID: 168293307
Max Phase: Preclinical
Molecular Formula: C19H12N2O4
Molecular Weight: 332.32
Associated Items:
Canonical SMILES: O=C(O)c1ccc2noc(-c3cccc(Oc4ccccn4)c3)c2c1
Standard InChI: InChI=1S/C19H12N2O4/c22-19(23)13-7-8-16-15(11-13)18(25-21-16)12-4-3-5-14(10-12)24-17-6-1-2-9-20-17/h1-11H,(H,22,23)
Standard InChI Key: RCLHIZBXRDCZCI-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 332.32 | Molecular Weight (Monoisotopic): 332.0797 | AlogP: 4.38 | #Rotatable Bonds: 4 |
| Polar Surface Area: 85.45 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
| #RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 3.63 | CX Basic pKa: 1.94 | CX LogP: 3.69 | CX LogD: 0.48 |
| Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.60 | Np Likeness Score: -1.25 |
| 1. Zhou Y, Mukherjee S, Huang D, Chakraborty M, Gu C, Zong G, Stashko MA, Pearce KH, Shears SB, Chakraborty A, Wang H, Wang X.. (2022) Development of Novel IP6K Inhibitors for the Treatment of Obesity and Obesity-Induced Metabolic Dysfunctions., 65 (9.0): [PMID:35467861] [10.1021/acs.jmedchem.2c00220] |
Source(1):
